NuvoTrim is a comparison service, not a pharmacy, medication or medical provider. We may earn a commission from some providers.How we make money
    NuvoTrim

    Lost GLP-1 coverage in 2027? What to do next.

    If your 2027 plan no longer covers a GLP-1 medicine, or has denied a prior authorization, two things are worth doing in order: check what your plan will still pay, and, if a prior authorization was denied, fill in a paperwork appeal letter to review with your prescriber. After that, compare official manufacturer self-pay programs. This page does not name a single cheapest product, because prices and coverage vary by plan and by person.

    Among firms with 5,000 or more workers that offer health benefits, KFF's 2026 Employer Health Benefits Survey, published October 22, 2026, found that 33% covered GLP-1 agonists when used primarily for weight loss. KFF's 2025 Employer Health Benefits Survey found that 43% of firms of that size covered these medicines when used primarily for weight loss.

    These figures describe 2025 and 2026 coverage at those firms, not a 2027 rate. They are context for people reviewing 2027 plan documents during open enrollment.

    Separately, ICER's 2025 Launch Price and Access Report, using IQVIA prescription data from January through March 2025, found that 62% of new-to-brand Zepbound prescriptions were rejected. Of those prescriptions, 43% were rejected for insurance non-coverage, 15% for prior authorization or step therapy, and 4% for other reasons; 34% were filled and 4% were abandoned after coverage. That is a claim-rejection snapshot, not a rate of successful appeals, and not a prediction for any one person.

    Compounded drugs are not FDA-approved. Education only, not medical advice. Talk to a licensed clinician before changing medicines.

    Frequently asked questions

    Did employers with 5,000 or more workers cut GLP-1 coverage for weight loss?

    At firms with 5,000 or more workers that offer health benefits, KFF found coverage of GLP-1 agonists when used primarily for weight loss fell from 43% in the 2025 survey to 33% in the 2026 survey, published October 22, 2026. That is a firm-level figure for those employers, not a count of people who lost coverage, and it is not a 2027 measurement.

    What should I do if my plan denied a prior authorization?

    Ask the plan for the denial in writing and the stated reason. Plans usually offer an internal appeal, with the deadline printed on the denial letter. A fill-in paperwork template on our coverage checker lets you enter your drug, plan, denial reason, and prescriber so you can review the letter with your prescriber before you send it. We do not suggest a drug, a dose, or a diagnosis, and this is not medical or insurance advice.

    Where do I compare official self-pay programs?

    After you check coverage, look at the manufacturer's official self-pay program page for the medicine your prescriber has already chosen. Eligibility and prices change, so read the program page directly. We do not recommend a medicine.

    Are compounded GLP-1 medicines FDA-approved?

    Compounded drugs are not FDA-approved.

    Is this medical advice?

    No. This page is education, not medical advice. Talk to a licensed clinician before changing medicines. Your plan's documents have the final word on coverage.

    Sources (checked Nov 10, 2026)